IBB icon

iShares Biotechnology ETF
IBB

Overview Fund Activity

306 hedge funds and large institutions have $4.42B invested in iShares Biotechnology ETF in 2014 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 81 increasing their positions, 117 reducing their positions, and 41 closing their positions.

Holders
306
Holders Change
+18
Holders Change %
+6.25%
% of All Funds
8.8%
Holding in Top 10
14
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-30%
% of All Funds
0.4%
New
60
Increased
81
Reduced
117
Closed
41
Calls
$439M
Puts
$675M
Net Calls
-$236M
Net Calls Change
-$115M

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$863M
2
Morgan Stanley
2
Morgan Stanley
New York
$573M
3
SG Americas Securities
3
SG Americas Securities
New York
$59.9M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$80.7M
5
HI
5
Honeywell International
North Carolina
$19.3M

Top Sellers

1
Citigroup
1
Citigroup
New York
$432M
2
Deutsche Bank
2
Deutsche Bank
Germany
$76.6M
3
Barclays
3
Barclays
United Kingdom
$190M
4
Mirae Asset Global Investments
4
Mirae Asset Global Investments
South Korea
$105M
5
Bank of Nova Scotia
5
Bank of Nova Scotia
Ontario, Canada
$0
Name Market Value Shares Shares
Change 		Shares
Change %
IPC
351
Independent Portfolio Consultants
Florida
– – – –
WMSA
352
Weiss Multi-Strategy Advisers
New York
– – – –
HT
353
HAP Trading
New York
– – – –
FRM
354
Fore Research & Management
New York
– – – –
AG
355
Artal Group
Luxembourg
– – – –
GF
356
Gerry Farber
New York
– – – –
CA
357
Continental Advisors
Utah
– – – –
DP
358
DSAM Partners
United Kingdom
– – – –
AC
359
Amici Capital
New York
– – – –
ACH
360
ArrowMark Colorado Holdings
Colorado
– – – –
BCMU
361
BlueCrest Capital Management (UK)
Guernsey
– – – –
NCM
362
Nantahala Capital Management
Connecticut
– – – –
SKK
363
Shepherd Kaplan Krochuk
Massachusetts
– – – –
KCM
364
Kingdon Capital Management
New York
– – – –
O
365
OrbiMed
New York
– – – –
11 12 13 14
15